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 Singlet oxygen and nitric oxide are simultaneously generated by green light  
 The molecular hybrid is not toxic in the dark towards healthy and cancer cells 
 Bimodal mortality of cancer cells is observed under green light excitation  
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Abstract 
Combination of photosensitizers (PS) for photodynamic therapy with NO photodonors (NOPD) is 
opening intriguing horizons towards new and still underexplored multimodal anticancer and 
antibacterial treatments not based on “conventional” drugs and entirely controlled by light stimuli. In 
this contribution, we report an intriguing molecular hybrid based on a BODIPY light-harvesting 
antenna that acts simultaneously as PS and NOPD upon single photon excitation with the highly 
biocompatible green light. The presented hybrid offers a combination of superior advantages with 
respect to the other rare cases reported to date, meeting most of the key criteria for both PSs and 
NOPDs in the same molecular entity such as: i) capability to generate 1O2 and NO with single photon 
excitation of biocompatible visible light, ii) excellent 1O2 quantum yield and NO quantum efficiency, 
iii) photogeneration of NO independent from the presence of oxygen, iv) large light harvesting 
properties in the green region. Furthermore, this compound together with its stable photoproduct, is 
well tolerated by both normal and cancer cells in the dark and exhibits bimodal photomortality of 
cancer cells under green light excitation due to the combined action of the cytotoxic 1O2 and NO. 
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1. Introduction 
Singlet oxygen (1O2) is the main species involved in photodynamic therapy (PDT), a well-established 
therapeutic modality for treating malignant lesions, including cancer, and a variety of microbial 
infections [1-4]. This promising treatment modality exploits the effects originated by the appropriate 
combination of Vis/NIR light with a photosensitizer (PS) in the presence of molecular oxygen [5]. 
Upon light absorption, the PS reaches its lowest-energy excited triplet state through intersystem 
crossing (isc). Due to the long lifetime, the triplet state can be quenched by nearby molecular oxygen 
mainly through energy transfer mechanisms, producing the highly reactive 1O2 in a photocatalytic 
fashion [6, 7]. 
Nitric oxide (NO), is an endogenous messenger that is ubiquitously produced by mammalian tissues 
and is involved in many physiological and pathophysiological processes [8, 9]. Besides, NO 
represents an intriguing therapeutic species with exciting prospects in healthcare, including cancer, 
bacteria, and cardiovascular diseases [10]. In this context, the light-controlled generation of NO 
achieved by using suitable NO photodonors (NOPDs), has recently received a great deal of attention 
for use as a potential new anticancer and antibacterial agents [11-13]. Indeed, unlike classical NO-
donors [14], these light-activated precursors allow the action of NO to be confined within the 
irradiated area with high spatial precision and its dosage, which is critical to observe therapeutic 
effects [15], to be controlled with great accuracy by tuning the duration and intensity of the irradiation 
[11-13]. In contrast to traditional PDT, the so-called NO-photodynamic therapy (NOPDT) [16] 
implies a net photochemical reaction to generate NO, which consumes the NOPD but, 
advantageously, does not require O2 availability to function. In particular, NOPDT may be useful in 
the treatment of hypoxic tumors and anaerobic bacteria, which are not responsive to classical PDT 
[17]. In recent years, a deal of attention has been devoted to the combination of PSs and NOPD as a 
very appealing strategy in view of multimodal therapeutic approaches entirely controlled by light 
[18]. This interest is motivated by the common features that 1O2 and NO share, such as small size, 
good lipophilicity and absence of charge, capability to be multitarget cytotoxic agents, absence of 
multidrug resistance, confinement of their action to short distances from the production site inside 
the cells due to their short lifetime in this environment (ca. 3 µs and ca. 5 s for 
1O2 and NO, 
respectively [7-9]), reducing systemic toxicity issues common to many conventional drugs. A number 
of supramolecular nanoconstructs assembling NOPDs and PDT PSs through appropriate carriers have 
been achieved in the recent years [18]. The non-covalent approach presents the advantage of the facile 
tuning of the relative concentrations of the photoactive guests; however, it may suffer displacement 
in a biological environment. In contrast, the covalent connection of the photoactive precursors within 
the same molecular skeleton ensures that the photodelivery events occur exactly in the “very same 
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region of space” of the cell components. Only a very limited number of examples of robust 
bifunctional systems integrating covalently PSs and NOPDs within the same molecular skeleton are 
known to date [19, 20]. Santana da Silva et al. reported an intriguing ruthenium-phthalocyanine 
complex having NO as axial ligand able to release NO and 1O2 under light excitation [20]. However, 
the presence of oxygen was strictly required for the mechanism leading to NO photorelease, 
precluding, in principle, the advantages that NO offers under hypoxic conditions (vide supra). 
Furthermore, the efficiency of NO photorelease dropped significantly down under excitation with 
visible light with respect to that observed under UV light. 
We recently reported the non-metal based molecular hybrid 2 (Scheme 1) in which a nitroaniline 
derivative NOPD was linked to a BODIPY derivative as PS [19]. These two chromogenic units 
represent independent light harvesting antennae in the blue and the green region of the visible 
spectrum, and their individual photochemical properties are conserved in the molecular conjugate. 
Thus, photogeneration of the cytotoxic 1O2 and NO can be observed simultaneously but only under 
concomitant excitation with both green and less biocompatible blue light. 
 
 
Scheme 1. Structures of the molecular hybrids 1 and 2 and working principle for the simultaneous release of 1O2 and NO 
upon photoexcitation of 1. 
 
This contribution reports the novel molecular hybrid 1 that overcomes the limitations of the above 
systems (Scheme 1). This compound can be easily obtained in one-step by nitrosation of compound 
2 (see SI) and represents the first example of molecular conjugate capable to generate simultaneously 
1O2 and NO exclusively upon excitation with the highly biocompatible green light. We demonstrate 
that these two biologically relevant species can be obtained by exploiting exclusively the BODIPY 
as a light-harvesting antenna. Single photoexcitation with green light triggers not only effective 
photogeneration of 1O2 but also the release of NO from the nitrosoaniline derivative, more likely due 
to an intramolecular electron transfer, forming compound 2 as the main stable co-product (Scheme 
1). 
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2. Results and Discussion 
Excitation of 1 at 532 nm leads to the generation of 1O2 in very high yield. In particular, 
1O2 was 
unequivocally detected and quantified by measuring its phosphorescence in the near-IR spectral 
window. Figure 1 shows the typical luminescence signal with maximum at ca. 1270 nm, observed for 
optically-matched solutions of 1 and, for comparison, of 2. The quantum yield for production of 1O2 
for the conjugate 1 was Δ = 0.90, which is basically the same to that observed for 2, suggesting that 
nitrosation of the nitroaniline moiety does not affect the photosensitizing properties of the BODIPY 
PS. 
 
 
Fig. 1. 1O2 luminescence detected upon 532 nm light excitation of optically matched methanol solutions of 1 () and 2 
(). 
 
Figure 2A shows the absorption spectrum of 1 and, for comparison, of 2. It can be seen that the typical 
absorption of the nitroaniline component at ca. 380 nm is much smaller in compound 1 and is 
accompanied by a new absorption at ca. 290 nm. This is a consequence of the loosing of the push-
pull character of the nitroaniline chromophore upon nitrosation. Furthermore, the absorption band 
due to the BODIPY component undergoes ca. 20% hyperchromic effect that would account for an 
electronic interaction between the BODIPY core and the nitroso-derivative appendage (vide infra) in 
the ground state. Irradiation of a solution of 1 with green light, leads to the absorption spectral changes 
illustrated in Figure 2B. 
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Fig. 2. (A) Absorption spectra of solutions of 1 (a) and, for comparison, 2 (b). (B) Absorption spectral changes observed 
upon exposure of a solution of 1 (7.5 µM) at exc = 532 nm for intervals from 0 to 40 min. The arrows indicate the course 
of the spectral profile with the illumination time. The inset shows the difference absorbance changes at  = 390 nm 
observed for air-equilibrated () and N2-saturated () solutions. H2O: MeOH (20:80 v/v). T = 25 °C. 
 
Interestingly, a decreasing of the absorption at  = 290 nm and  = 527 nm and the restoring of the 
absorption at  = 380 nm, typical for the nitroaniline unit of compound 2, characterize the spectral 
profile evolution. These spectral changes are accompanied by the presence of two clear isosbestic 
points, which are indicative of the occurrence of a very clean photochemical reaction. Note that, the 
spectrum at the end of the photolysis is basically identical to that of compound 2 (see spectrum b in 
Fig. 2A). This behavior provides a first indication for the release of NO from 1 and would account 
for the formation of 2 as stable co-product. This hypothesis was confirmed by HPLC analysis of the 
irradiated reaction mixture that revealed 2 as the sole photolysis stable product (Fig. S1). Moreover, 
experiments carried out with N2-saturated solutions showed that the presence of oxygen affects 
neither the nature nor the efficiency of the photolysis (Fig. 2B, inset and Fig. S2). This finding 
suggests that NO photorelease takes place independently from oxygen and rules out the participation 
of the long-lived excited triplet state as a key intermediate in the mechanism of the NO photorelease. 
The release of NO with green light was proven by the direct detection of this species through 
amperometric techniques using an ultrasensitive NO electrode. Figure 3 shows unambiguously that 
NO release by 1 takes place exclusively under light stimuli whereas stops in the dark and restarts 
again once the light is turned on. 
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Fig. 3 NO release profile observed upon 532 nm light irradiation of a solution of 1 (7.5 µM). H2O:MeOH (20:80 v/v). T 
= 25 °C. 
 
The quantum yield for the photodecomposition of 1, P, was 0.002 0.0005. This value is comparable 
with others organic NOPDs activatable with green light [21, 22]. Furthermore, it needs to be 
considered that the efficiency of photoinduced reactions is, in general, expressed as the product of 
maxP (quantum efficiency). In our case, the large value of max (59.000 M–1 cm–1) gives a product 
maxP 120. Such a value is larger than the values reported for other organic NOPDs (maxP = 
10−70) [23, 24] that, however, can be solely controlled with relatively toxic blue light, and is on the 
same order of magnitude than that recently observed of another NOPD activatable by green light [21, 
22] which, however, does not produce 1O2. 
Since the BODIPY unit is the sole chromophore absorbing the green light, photorelease of NO from 
the nitro-derivative moiety must necessarily involve an electronic communication between these two 
components. Photoinduced energy transfer from the excited BODIPY to the nitroso-derivative 
appendage is, of course, out of question because it is thermodynamically uphill [25]. More likely, the 
uncaging of NO from 1 seems to be triggered by a photoinduced electron transfer from the 
nitrosoaniline-derivative moiety, as electron donor, to the excited singlet state of the BODIPY, as 
electron acceptor. This process encourages the detachment of NO from 1, according to what recently 
observed by Nakagawa et al. for other BODIPYs conjugates working under blue light excitation [24], 
and is expected to generate a nitroaniline-derivative radical intermediate (see Scheme 2). Such a 
species is very stable, almost insensitive to the presence of oxygen and can evolve to the stable 
photoproduct 2 upon H-abstraction from solvent, in excellent agreement with the identical photolytic 
behavior observed in aerobic and anaerobic conditions (Figs. 2B and S2). 
Our proposal is supported by a considerable change in free energy for the photoinduced electron 
transfer process, G  –0.4 eV estimated by the Rehm-Weller equation [26]: 
 
G = e[Eox – Ered] – E0,0 
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where Eox is the half-wave potential for one-electron oxidation of the electron-donor unit (ca. 1 eV 
vs. SCE) [27] Ered is the half-wave potential for one-electron reduction of the electron-acceptor unit 
(ca. –1 eV vs. SCE) [28, 29] and E0,0  is the energy of the lowest excited singlet state of the BODIPY 
antenna (ca. 2.4 eV) [30].  The emissive behavior of 1 is in excellent agreement with this view. In 
fact, the fluorescence quantum yield of 1 was f = 0.044, a value smaller than that observed for the 
non-nitrosate derivative 2, f = 0.047 (Fig. S3). Such a difference accounts very well for the occurrence 
of the photodecomposition process leading to the NO release, competitive with the fluorescence 
emission in the hybrid 1. Photoinduced electron transfer between two species separated by an insulator 
spacer like in the case of 1, requires, of course, their very close spatial proximity. The hyperchromic 
effect noted in the absorption spectrum of 1, when compared with the non-nitrosated derivative 2 
(Fig. 2A) is in line with an interaction between the electron donor and the acceptor. This is well 
corroborated by molecular dynamics (MD) simulation of 50 ns and the subsequent optimization of 
the most stable conformer at B3LYP DFT level. The obtained conformer (Fig. 4A) shows an evident 
U-shape like geometry in which the aromatic systems of both BODIPY and nitrosoaniline-derivative 
moieties are facing each other, almost in parallel, generating secondary orbital stabilizing interactions. 
In particular, from the results of the secondary-order perturbation theory (SOPT) analysis of the Fock 
matrix in NBO basis, according to the definition of delocalization energy given by Weinhold [31, 
32], emerged that the U-shaped conformer is stabilized by a series of delocalizations of which the 
main are the n* (1.20 kcal/mol) between the lone pair of O41 and the antibonding orbital of the 
C14–H52 single bond and another three n* (1.26, 0.83, and 0.29 kcal/mol) due to the F10 lone pairs 
with the antibonding orbital of the C43–H72 single bond (Fig. 4B), for a total stabilization of 3.58 
kcal/mol. Moreover, a hydrogen bond interaction between the amidic hydrogen atom and the oxygen 
atom of the N-nitroso moiety gives further rigidity to the distal part of the tethering trimethylene chain 
(2.31 kcal/mol, Fig. 4). 
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A B  
Fig. 4. A) Ball and stick representation of the most stable conformer of compound 1 in its ground state. B) Principal 
secondary orbital interactions of compound 1 in its most stable U-shaped conformation as derived by the SOPT analysis. 
 
A general mechanism accounting for the photogeneration of 1O2 and NO from 1 and according to the 
experimental results is proposed in Scheme 2. 
 
 
Scheme 2. General mechanism for the simultaneous release of 1O2 and NO upon green light excitation of the molecular 
hybrid 1. 
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Preliminary biological test performed to ascertain the biocompatibility of compound 1 and its stable 
photoproduct 2, were carried out with human fibroblasts and A375 and HepG2 cancer cell lines. 
Figure S4 shows that both the molecular hybrids are well tolerated in the dark up to 10 µM by normal 
and tumor cells. Note that, although low, such a concentration range is enough to make 1 able to 
absorb considerable green light due to its large molar absorptivity (Fig. 2A). To validate the feasibility 
of the molecular hybrid 1 as a powerful bimodal phototherapeutic agent activatable with green light, 
the above cancer cell lines were incubated with 1 and, for comparison, with the same concentration 
of 2, and either kept in the dark or irradiated for 5 min with a green light source. Cell cytotoxicity 
was determined using the MTT assay 24 h after completion of irradiation. The results in Figure 5 
account for a marked cell mortality under illumination in the presence of both compounds. In 
particular, the extent of photomortality induced by 1, able to photogenerate simultaneously 1O2 and 
NO, was greater than that observed for compound 2 which, in contrast, does not produce NO under 
green light excitation. Such a difference being much more evident in the case of the HepG2 cancer 
cells. These findings provide clear-cut evidence for the involvement of a bimodal photo-inactivation 
mechanism in neoplastic destruction, in which the simultaneous release of cytotoxic NO and 1O2 is 
envisaged to play a key role. At first sight, the observed bimodal action can seem surprising in view 
of the large difference in the photogeneration efficiency of NO and 1O2 by 1. This could be due to the 
different mechanism of action of these two species, according to what already proposed in the 
literature [20]. Mechanistic studies addressed to shed light into this issue are already ongoing in our 
laboratories. 
 
 
Figure 5. Cell viability of A375 and HepG2 cancer cells incubated 4h with 1 and 2 and either kept in the dark or irradiated 
for 5 min with green light (528 nm ≈0.5 mW cm–2) [1] = [2] = 5 µM. 
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3. Conclusions 
In conclusion, we have reported an intriguing molecular system which, to the best of our knowledge, 
represents the first example of a molecular hybrid offering a combination of superior advantages with 
respect to the other few examples reported to date. In fact, it meets most of the key criteria for both 
PSs and NOPDs in the same molecular entity such as: i) capability to generate 1O2 and NO with single 
photon excitation of biocompatible green light, ii) excellent 1O2 quantum yield and NO quantum 
efficiency, iii) photogeneration of NO independent from the presence of oxygen, iv) large light 
harvesting properties in the green region. Furthermore, this compound can be easily obtained in one 
single step from 2 and, together with its stable photoproduct, is well tolerated by both normal and 
cancer cells in the dark and exhibits bimodal photomortality of cancer cells under green light 
excitation due to the combined action of NO and 1O2. These properties make 1 a very appealing 
candidate for a variety of forthcoming biomedical studies, especially on anticancer and antibacterial 
research. 
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